If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 111 - 120 of 299
A Randomized, Masked, Placebo Controlled, Phase II Trial of Concurrent Chemoradiation with BMX-001 in Patients with Head and Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
Objective
Study of BMX-001 radioprotector with chemoradiation therapy for H/N cancer patients
Protocol No
NRG-CC013
Categories
A Measurable Residual Disease (MRD) Focused, Phase II Study of Venetoclax Plus Chemotherapy for Newly Diagnosed Younger Patients with Intermediate Risk Acute Myeloid Leukemia: A Tier 1 MYELOMATCH Clinical Trial
Objective
Comparing cytarabine + daunorubicin therapy versus cytarabine + daunorubicin + venetoclax versus venetoclax + azacitidine in younger patients with intermediate risk AML
Protocol No
CCTG-MM1YA-CTG01
Categories
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of IMPT-314, a CD19/20 Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy in Participants with Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Objective
The purpose of this research is to find new ways to treat lymphomas that have either come back after treatment or have stopped responding to treatment.
Protocol No
IMMPACT-MPCT-012L
Categories
PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer
Objective
PLDR CRT for esophageal cancer
Protocol No
IIT-PUCKETT-PULSO
Categories
An Open-Label, Phase 1, Multi-Center Study to Evaluate the Safety and Preliminary Anti-Tumor Activity of NT-112 in Human Leukocyte Antigen-C*08:02-Positive Adult Subjects with Unresectable, Advanced and/or Metastatic Solid Tumors That Are Positive fo
Objective
A Phase1 Study of NT-112 in Patients with Advanced Solid Tumors Positive for KRAS G12D Mutation
Protocol No
NEOGENE-NT-112-301
Early versus Late Endoscopic Temporary Stenting for Management of Refractory Benign Esophageal Strictures
Objective
Early vs Late Endoscopic Stenting for RBES
Protocol No
GI-IIT-DUA-RBES
Categories
RECOVER-SLEEP: A Platform Protocol for Evaluation of Interventions for Sleep Disturbances in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Objective
RECOVER-SLEEP: Platform Protocol
Protocol No
PULM-DUKE-RECOVER-SLEEP
Categories
An Open-Label, Multicenter Study of LY4050784, a Selective SMARCA2/BRM Inhibitor, in Advanced Solid Tumor Malignancies with SMARCA4/BRG1 Alterations
Objective
An Open-label, Multicenter Study of LY4050784 in Advanced Solid Tumor Malignancies with SMARCA4/BRG1 Alterations
Protocol No
LOXO-J5M-OX-JOXA
Categories
Cancer,
Stomach,
Prostate,
Breast Cancers,
Other Skin,
Lip, Oral Cavity and Pharynx,
Larynx,
Ovary,
Head and Neck Cancers,
Thoracic Cancers,
Sarcoma,
Other Urologic,
Pancreas/Liver,
Cervix,
Gynecologic Cancers,
Esophagus,
Melanoma, Skin,
Bladder,
Gastrointestinal Cancers,
Prostate and Urologic Cancers,
Early Phase/Multiple Disease Site Cancers,
Skin Cancers
WATCHMAN FLX Pro Left Atrial Appendage Closure Device With Alternative Post-Implant Monotherapy
Objective
SIMPLAAFY Clinical Trial
Protocol No
CVC-BOSTONSCI-SIMPLAAFY
Categories
A Phase 1b, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, and Feasibility of Neoadjuvant Xaluritamig Therapy Prior to Radical Prostatectomy in Subjects with Newly Diagnosed Localized Intermediate or High-Risk Prostate Cancer
Objective
A Phase 1B Study of Neoadjuvant Xaluritamig Therapy in Patients with Newly Diagnosed Localized Intermediate or High Risk Prostate Cancer
Protocol No
AMGEN-AMG-509-20230237
Categories